← FDA Drug Approvals (Drugs@FDA)

AMPHETAMINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2019-08-05

Drug application

FDA Application #

ANDA212619

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMPHETAMINE SULFATE

Generic name

AMPHETAMINE SULFATE

Active ingredients

AMPHETAMINE SULFATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GRANULES

Manufacturer

Granules Pharmaceuticals Inc.

First approval

2019-08-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown